Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Ann Intern Med. 2021 Oct;174(10):1468-1469. doi: 10.7326/M21-2680. Epub 2021 Jun 29.
In their article, Sangli and colleagues described catastrophic thrombosis after the second dose of the SARS-CoV-2 messenger RNA–1273 vaccine from Moderna. The editorialists discuss vaccine-induced thrombosis and thrombocytopenia and thrombosis with thrombocytopenia syndrome and why this case cannot be definitively attributed to the vaccine. They also note that the remarkable speed with which clinicians and scientists have recognized this rare entity and developed evidence-based diagnosis and treatment guidelines should bolster public confidence in postlicensure vaccine safety monitoring.
在他们的文章中,Sangli 和同事描述了 Moderna 的 SARS-CoV-2 信使 RNA-1273 疫苗第二剂后发生的灾难性血栓形成。社论作者讨论了疫苗引起的血栓形成和血小板减少症,以及血栓形成伴血小板减少综合征,以及为什么不能将此病例明确归因于疫苗。他们还指出,临床医生和科学家以如此惊人的速度认识到这种罕见实体,并制定了基于证据的诊断和治疗指南,这应该增强公众对疫苗上市后安全性监测的信心。